KRAS and colorectal cancer: Colorectal cancer patients with KRAS mutations are often associated with poor prognosis, less responsive to certain targeted therapies, and have a higher risk of disease recurrence when compared to patients with wild-type KRAS [301,302,303,304,305,306].